The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional randomized controlled trials (RCTs), computational modeling and simulation (CM&S ...

Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...

Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical trial actually requires of participants, regulators, and the company ...

The durability of communication with the use of brain–computer interfaces in persons with progressive neurodegenerative disease has not been extensively examined. We report on 7 years of independent ...

Brain chip technology advances rapidly as startups expand trials, raising ethical, safety, and privacy concerns worldwide.